| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Revenues: |
| UNITED STATES | 14.5 | 14.0 | 15.5 | 15.0 | | 11.1 | 10.5 | 6.7 |
| Government Contracts Concentration Risk | 27.7 | 13.7 | 15.1 | 14.9 | | 11.1 | 10.5 | 6.6 |
| Total revenues | 19.3 | 18.4 | 19.4 | 16.9 | | 13.9 | 11.5 | 7.9 |
| Revenue growth [+] | | 32.4% | 69.0% | 113.4% | | 90.5% | 79.3% | 49.3% |
| UNITED STATES | | 25.8% | 47.4% | 123.7% | | 82.1% | | |
| Government Contracts Concentration Risk | | 23.4% | 43.8% | 125.8% | | 82.0% | 94.4% | |
| Cost of goods sold | 8.5 | 6.5 | 7.3 | 7.8 | | 11.0 | 10.2 | 12.7 |
| Gross profit | 10.8 | 11.9 | 12.1 | 9.1 | | 2.9 | 1.3 | -4.7 |
| Gross margin | 55.9% | 64.8% | 62.4% | 54.0% | | 21.2% | 11.4% | -59.4% |
| Selling, general and administrative [+] | 18.8 | 18.9 | 20.7 | 18.7 | | 22.5 | 28.7 | 40.7 |
| General and administrative | | | 20.7 | | | | 28.7 | |
| Research and development | 0.2 | 0.2 | 0.3 | 0.2 | | 0.1 | 0.0 | 0.1 |
| Equity in earnings | 0.1 | 0.5 | 1.4 | -0.8 | | 0.3 | 0.2 | -0.2 |
| EBITDA [+] | -8.1 | -6.7 | -7.5 | -10.5 | | -19.5 | -27.2 | -45.6 |
| EBITDA growth | | -65.5% | -72.5% | -76.9% | | 198.7% | 398.3% | 349.8% |
| EBITDA margin | -41.8% | -36.5% | -38.4% | -62.2% | | -140.2% | -236.4% | -574.7% |
| Depreciation and amortization | 11.8 | 9.7 | 9.5 | 9.6 | | 7.4 | 4.5 | 3.5 |
| EBIT [+] | -19.9 | -16.4 | -17.0 | -20.1 | | -26.9 | -31.7 | -49.1 |
| EBIT growth | | -39.1% | -46.4% | -59.0% | | 189.4% | 259.6% | 282.8% |
| EBIT margin | -102.8% | -89.0% | -87.3% | -118.9% | | -193.4% | -275.6% | -618.9% |
| Interest expense, net [+] | 1.6 | 1.4 | 1.2 | 0.7 | | 1.3 | 1.5 | 1.2 |
| Interest expense | 2.2 | 1.9 | 1.7 | 1.2 | | 1.3 | 1.5 | 1.2 |
| Interest income | 0.6 | 0.4 | 0.5 | 0.5 | | | | |
| Other income (expense), net [+] | -12.0 | 0.6 | 3.3 | 7.1 | | 8.1 | 39.2 | 3.4 |
| Unrealized gain/loss on derivatives | -11.1 | 1.5 | 1.2 | 7.1 | | 8.1 | 35.0 | 3.8 |
| Change in fair value of warrants | -11.1 | 1.5 | 1.2 | 7.1 | | 8.1 | 35.0 | 3.8 |
| Other | -0.9 | -0.9 | 2.1 | 0.0 | | 0.0 | 0.1 | -0.4 |
| Pre-tax income | -33.4 | -17.2 | -14.9 | -13.8 | | -20.0 | 6.0 | -46.9 |
| Income taxes | 0.0 | 0.1 | 0.0 | 0.0 | | 0.0 | 0.0 | 0.0 |
| Tax rate | | | 0.0% | 0.0% | | 0.0% | 0.0% | 0.0% |
| Net income | -33.4 | -17.3 | -14.9 | -13.0 | | -20.0 | 5.4 | -46.9 |
| Net margin | -173.0% | -94.1% | -76.5% | -77.0% | | -143.9% | 47.0% | -590.9% |
| |
| Basic EPS [+] | ($0.24) | ($0.14) | ($0.13) | ($0.12) | | ($0.17) | $0.08 | ($0.67) |
| Growth | | -19.4% | -251.7% | -82.7% | | -75.1% | -127.1% | 65.0% |
| Diluted EPS [+] | ($0.24) | ($0.14) | ($0.13) | ($0.12) | | ($0.17) | $0.08 | ($0.67) |
| Growth | | -19.4% | -251.7% | -82.7% | | -75.1% | -127.1% | 65.0% |
| |
| Shares outstanding (basic) [+] | 137.2 | 124.1 | 117.8 | 118.6 | | 115.5 | 72.5 | 70.0 |
| Growth | | 7.5% | 62.6% | 69.5% | | -52.3% | 119.5% | 104.3% |
| Shares outstanding (diluted) [+] | 137.2 | 124.1 | 117.8 | 118.6 | | 115.5 | 72.5 | 70.0 |
| Growth | | 7.5% | 62.6% | 69.5% | | -52.3% | 119.5% | 104.3% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |